Your browser doesn't support javascript.
Clinical characteristics of asymptomatic carriers of novel coronavirus disease 2019: A multi-center study in Jiangsu Province.
Chen, Jiaxin; Han, Tao; Huang, Mao; Yang, Yi; Shang, Futai; Zheng, Yishan; Zhao, Wenjing; Luo, Liang; Han, Xudong; Lin, Aihua; Zhao, Hongsheng; Gu, Qin; Shi, Yi; Li, Jun; Xu, Xingxiang; Liu, Kexi; Deng, Yijun; Jia, Enzhi; Cao, Quan.
  • Chen J; Department of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu Province, China.
  • Han T; Department of Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu Province, China.
  • Huang M; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu Province, China.
  • Yang Y; Department of Critical Care Medicine, Zhongda Hospital of Southeast University , Nanjing, Jiangsu Province, China.
  • Shang F; Department of Critical Care Medicine, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University , Huaian, Jiangsu Province, China.
  • Zheng Y; Department of Critical Care Medicine, Nanjing No.2 Hospital , Nanjing, Jiangsu Province, China.
  • Zhao W; Department of Critical Care Medicine, The Affiliated Hospital of Xuzhou Medical University , Xuzhou, Jiangsu Province, China.
  • Luo L; Department of Critical Care Medicine, Wuxi No. 2 People's Hospital , Wuxi, Jiangsu Province, China.
  • Han X; Department of Critical Care Medicine, The Third People's Hospital of Nantong City Affiliated to Nantong University , Nantong, Jiangsu Province, China.
  • Lin A; Department of Critical Care Medicine, Suqian People's Hospital of Nanjing Gulou Hospital Group , Suqian, Jiangsu Province, China.
  • Zhao H; Department of Critical Care Medicine, The Affiliated Hospital of Nantong University , Nantong, Jiangsu Province, China.
  • Gu Q; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Nanjing University Medical School , Nanjing, Jiangsu Province, China.
  • Shi Y; Department of Pulmonary and Critical Care Medicine, Nanjing Jinlin Hospital , Nanjing, Jiangsu Province, China.
  • Li J; Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu Province, China.
  • Xu X; Department of Pulmonary and Critical Care Medicine, Northern Jiangsu People's Hospital , Yangzhou, Jiangsu Province, China.
  • Liu K; Department of Critical Care Medicine, Lianyungang First People's Hospital , Lianyungang, Jiangsu Province, China.
  • Deng Y; Department of Critical Care Medicine, Yancheng First People's Hospital , Yancheng, Jiangsu Province, China.
  • Jia E; Department of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu Province, China.
  • Cao Q; Department of Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu Province, China.
Virulence ; 11(1): 1557-1568, 2020 12.
Artículo en Inglés | MEDLINE | ID: covidwho-900311
ABSTRACT
Asymptomatic SARS-CoV-2-infected individuals are thought to play major roles in virus transmission. This study aimed to analyze the characteristics of asymptomatic carriers with COVID-19 to control the spread of the virus. We retrospectively investigated the clinical characteristics of 648 consecutive subjects who were enrolled in the study and were divided into asymptomatic carriers, mild cases, ordinary cases, severe or critical cases, and evaluated their impact on disease severity by means of Spearman correlation and multiple regression analyses. Receiver operating characteristic curve analysis was conducted to determine the optimum cutoff levels of laboratory findings for diagnostic predictors of asymptomatic carriers of COVID-19. In our study, a total of 648 subjects on admission with a mean age of 45.61 y including 345 males and 303 females were enrolled in our study. The leukocyte, lymphocyte, eosinophil, platelet, C-reactive protein, interleukin-6, CD3+, CD4+, and CD8 + T lymphocyte levels, and the erythrocyte sedimentation rate differed significantly among the groups (all p ≤ 0.05). Disease severity was negatively associated with the CD3+ (r = -0.340; p < 0.001), CD4+ (r = -0.290; p = 0.001) and CD8+ (r = -0.322; p < 0.001) T lymphocyte levels. The significant diagnostic predictors of asymptomatic carriers of COVID-19 included the blood cell, cytokine, and T lymphocyte subset levels. Inflammation and immune response may play important roles in disease progression. Hence, the laboratory parameters identified should be considered in clinical practice, which provide new insights into the identification of asymptomatic individuals and the prevention of virus transmission.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Infecciones Asintomáticas Tipo de estudio: Estudios diagnósticos / Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Covid persistente / Variantes Límite: Adolescente / Adulto / Anciano / Niño / Child, preschool / Femenino / Humanos / Lactante / Masculino / Middle aged País/Región como asunto: Asia Idioma: Inglés Revista: Virulence Año: 2020 Tipo del documento: Artículo País de afiliación: 21505594.2020.1840122

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Infecciones Asintomáticas Tipo de estudio: Estudios diagnósticos / Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Covid persistente / Variantes Límite: Adolescente / Adulto / Anciano / Niño / Child, preschool / Femenino / Humanos / Lactante / Masculino / Middle aged País/Región como asunto: Asia Idioma: Inglés Revista: Virulence Año: 2020 Tipo del documento: Artículo País de afiliación: 21505594.2020.1840122